Pacific Smiles Group Ltd (ASX: PSQ) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Pacific Smiles Group Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$311.98 million
P/E Ratio
36.80
Dividend Yield
2.91%
Shares Outstanding
159.58 million
Earnings per share
0.050
Dividend per share
0.05
Year To Date Return
24.04%
Earnings Yield
2.72%
Franking
100%
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Pacific Smiles Group Ltd (ASX: PSQ)
Latest News
Dividend Investing
8 ASX All Ords shares with ex-dividend dates next week
Mergers & Acquisitions
2 OTHER ASX shares rocketing on takeover offers today
Earnings Results
2 small ASX healthcare shares sprouting green after FY24 results
Share Gainers
Why Boss Energy, Pacific Smiles, Perpetual, and ResMed shares are racing higher
Mergers & Acquisitions
Why this ASX All Ords stock is sparkling 15% brighter today
Mergers & Acquisitions
Guess which ASX All Ords share just rocketed 18% on takeover news
Earnings Results
4 ASX healthcare shares charging higher on positive earnings updates
Share Market News
5 ASX All Ords shares just upgraded by top brokers
Healthcare Shares
'Highly sought-after': 3 ASX healthcare shares ready to roar again
Broker Notes
'Revenues up 59%': 3 small-cap ASX shares rocketing right now (and set for more gains)
Dividend Investing
4 ASX All Ordinaries shares trading ex-dividend on Wednesday
Frequently Asked Questions
-
Yes, Pacific Smiles Group has historically paid one or two fully franked shareholder dividends a year.
-
Pacific Smiles Group Limited list on the ASX on 21 November 2014.
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 24 Sep 2024 | $0.0325 | 100.00% | Final | 10 Oct 2024 |
| 21 Mar 2024 | $0.0210 | 100.00% | Interim | 05 Apr 2024 |
| 21 Sep 2023 | $0.0227 | 100.00% | Final | 09 Oct 2023 |
| 22 Mar 2023 | $0.0035 | 100.00% | Interim | 06 Apr 2023 |
| 24 Mar 2021 | $0.0240 | 100.00% | Interim | 09 Apr 2021 |
| 18 Mar 2020 | $0.0240 | 100.00% | Interim | 01 May 2020 |
| 18 Sep 2019 | $0.0350 | 100.00% | Final | 04 Oct 2019 |
| 18 Mar 2019 | $0.0230 | 100.00% | Interim | 05 Apr 2019 |
| 19 Sep 2018 | $0.0380 | 100.00% | Final | 05 Oct 2018 |
| 16 Mar 2018 | $0.0230 | 100.00% | Interim | 04 Apr 2018 |
| 14 Sep 2017 | $0.0000 | 100.00% | Final | 03 Oct 2017 |
| 15 Sep 2016 | $0.0350 | 100.00% | Final | 04 Oct 2016 |
| 15 Mar 2016 | $0.0200 | 100.00% | Interim | 01 Apr 2016 |
PSQ ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Pacific Smiles Group Ltd
Pacific Smiles Group Limited (ASX: PSQ) operates more than 120 dental centres nationally while more than 800 dentists operate their practices under the company's framework. In those practices, Pacific Smiles provides facilities, dental equipment, and support staff, while dental practitioners maintain clinical autonomy. The group owns and operates Pacific Smiles Dental and nib Dental Care centres across Australia's east coast and also manages operations of HBF Dental Centres in Western Australia.
PSQ Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 15 Nov 2024 | $1.96 | $0.00 | 0.00% | 8,315 | $1.95 | $1.96 | $1.95 |
| 14 Nov 2024 | $1.96 | $0.01 | 0.51% | 435,632 | $1.96 | $1.96 | $1.96 |
| 12 Nov 2024 | $1.95 | $0.00 | 0.00% | 409,774 | $1.95 | $1.96 | $1.95 |
| 11 Nov 2024 | $1.95 | $0.06 | 3.17% | 1,959,313 | $1.95 | $1.95 | $1.95 |
| 08 Nov 2024 | $1.89 | $0.06 | 3.28% | 3,617 | $1.84 | $1.89 | $1.84 |
| 05 Nov 2024 | $1.83 | $-0.07 | -3.68% | 90,011 | $1.83 | $1.83 | $1.83 |
| 04 Nov 2024 | $1.90 | $0.00 | 0.00% | 144 | $1.90 | $1.90 | $1.90 |
| 01 Nov 2024 | $1.90 | $-0.01 | -0.52% | 1,419 | $1.90 | $1.90 | $1.90 |
| 31 Oct 2024 | $1.91 | $-0.01 | -0.52% | 523 | $1.91 | $1.91 | $1.91 |
| 30 Oct 2024 | $1.92 | $0.04 | 2.14% | 686,228 | $1.87 | $1.92 | $1.84 |
| 29 Oct 2024 | $1.87 | $0.04 | 2.19% | 20,630 | $1.84 | $1.87 | $1.84 |
| 28 Oct 2024 | $1.83 | $0.00 | 0.00% | 4,904 | $1.85 | $1.87 | $1.83 |
| 25 Oct 2024 | $1.83 | $-0.01 | -0.54% | 2,700 | $1.84 | $1.87 | $1.83 |
| 24 Oct 2024 | $1.85 | $-0.03 | -1.60% | 3,151 | $1.87 | $1.87 | $1.84 |
| 22 Oct 2024 | $1.87 | $0.01 | 0.54% | 18,101 | $1.86 | $1.88 | $1.86 |
| 21 Oct 2024 | $1.86 | $0.00 | 0.00% | 6,775 | $1.87 | $1.87 | $1.86 |
| 18 Oct 2024 | $1.86 | $0.00 | 0.00% | 5,138 | $1.87 | $1.87 | $1.86 |
| 17 Oct 2024 | $1.86 | $-0.01 | -0.53% | 11,757 | $1.86 | $1.87 | $1.86 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 27 Nov 2023 | Jodie Leonard | Buy | 22,500 | $20,250 |
On-market trade.
|
| 24 Nov 2023 | Giselle Collins | Buy | 10,000 | $9,450 |
On-market trade.
|
| 24 Nov 2023 | Steven Rubic | Buy | 100,000 | $92,000 |
On-market trade.
|
| 24 Nov 2023 | Zita Peach | Buy | 55,000 | $51,095 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Brent Cubis | Non-Executive Director | Oct 2024 |
Mr Cubis was Chief Financial Officer at a number of healthcare and multi-site businesses including Cochlear Ltd, National Home Doctor Service Ltd, Fitness First Ltd and Chris OBrien Lifehouse Ltd. Following his executive career, he has held a number of Non-Executive director roles and is currently a Non-Executive Director on the boards of AI Media, ARN Media and Silverchain Group and is the Chair of the Audit & Risk Committee for each of these companies.
|
| Mr Gary Carroll | Non-Executive Director | Oct 2024 |
--
|
| Ms Jodie Lee Leonard | Non-Executive Director | May 2023 |
Ms Leonard portfolio focuses on scaling companies for growth and transforming business models to drive profitability. She understands ASX and regulated entity governance and has also chaired both Risk and Audit committees. Jodie has expertise in strategic planning, digital innovation, and marketing, with expertise across a diverse range of industries including technology, banking and financial services, consumer goods, healthcare, media, and travel and tourism.
|
| Ms Giselle Marie Collins | Non-Executive Director | Nov 2023 |
Ms Collins is Chair of Risk Management Committee. Collins has executive experience in property, tourism and financial services and has worked in professional services with KPMG in Sydney, London and Zug, Switzerland and at National Roads and Motorists Association Limited (NRMA) as GM in charge of Treasury, Property, Holiday Parks and the investment in the Travelodge Hotel Group
|
| Dr Scott Kalniz | Non-Executive Director | Jan 2021 |
Dr Kalniz is member of Risk Management Committee. Kalniz has over 25 years of dental industry experience in the United States. Dr Kalniz's current role is Chief Dental Officer and VP of Network Development at Beam Benefits, an employee benefits company. Dr Kalniz is also a director on the following private equity boards: Signature Dental Partners, Premier Dentist Partners, and Smiles America Partners. He started his career as a practising dentist with a single location practice and purchased several other dental practices, eventually selling his group to North American Dental.
|
| Mr Steven Rubic | Non-Executive Director | May 2023 |
Mr Rubic has over 30 years of healthcare Executive leadership experience including CEO roles at Healthscope, I-MED Radiology Network and St Vincent's & Mater Health. Steven is currently a Non-Executive Director of the Mercy Partners Mater Misericordiae Limited, Invocare Ltd and Catholic Healthcare Limited, and was previously the Chair of Monte Sant Angelo Mercy College, and formerly a Board Director of the Garvan Institute of Medical Research, the Chris O'Brien Lifehouse, the Macquarie University Council, Healthscope and the NSW Private Hospitals Association. He is also a member of the Property Committeee.
|
| Ms Belinda Ann Cleminson | Company Secretary | Aug 2021 |
-
|
| Paul Robertson | Chief Commercial Officer |
-
|
|
| Matthew Cordingley | Chief Financial Officer |
-
|
|
| Belinda Ann Cleminson | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limited | 52,962,823 | 33.19% |
| Beam Investments Co Pty Ltd | 31,750,000 | 19.90% |
| Alison Jane Hughes | 15,797,850 | 9.90% |
| Citicorp Nominees Pty Limited | 11,463,938 | 7.18% |
| Dr Alexander John Abrahams | 11,450,000 | 7.17% |
| BNP Paribas Nominees Pty Ltd (DRP) | 4,468,068 | 2.80% |
| J P Morgan Nominees Australia Pty Limited | 4,348,311 | 2.72% |
| Channings Holdings Pty Ltd (The Khan Holdings A/C) | 2,090,150 | 1.31% |
| Karen Wright | 2,022,000 | 1.27% |
| Mrs Susan Louise Abrahams | 2,000,000 | 1.25% |
| Just Paddling Pty Ltd (Rosebrook Super Fund A/C) | 1,954,646 | 1.22% |
| Mr Trevor Collins & Mrs Dianne Elizabeth Collins (The Trevor Collins Fam A/C) | 1,128,480 | 0.71% |
| Dr David Roessler | 766,200 | 0.48% |
| Mr Christopher Fergusson (Fergusson Holding A/C>) | 583,986 | 0.37% |
| BNP Paribas Nominees Pty Ltd (AGENCY LENDING DRP A/C) | 526,707 | 0.33% |
| Peter David Wade (WADE FAMILY A/C) | 523,862 | 0.33% |
| Inglenook Super Pty Ltd (Cameron Family S/F A/C>) | 500,000 | 0.31% |
| Lanlex No 93 Pty Ltd | 464,626 | 0.29% |
| Dr Allan Chow | 450,000 | 0.28% |
| Palm Beach Nominees Pty Limited | 428,429 | 0.27% |
